Investigation announced for Investors in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI)

An investigation was announced concerning potential securities laws violations by Treace Medical Concepts, Inc. in connection with certain financial statements.

Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Treace Medical Concepts, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Ponte Vedra, FL based Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.

Treace Medical Concepts, Inc. reported that its Total Revenue rose from $57.36 million in 2020 to $94.41 million in 2021, and that its Net Loss increased from $3.66 million in 2020 to $20.55 million in 2021.

On November 15, 2022, Culper Research published a short report on Treace Medical Concepts, Inc. (the "Culper Report"). The Culper Report expressed the "view that Treace's primary innovation has not been in any sort of medical advancements, but in aggressive reimbursement practices and deceptive DTC marketing," which the Culper Report described "as problematic and self-defeating, as insurers appear to have begun placing Lapiplasty procedure reimbursements under scrutiny while customer complaints about misleading claims from Treace are mounting."

Those who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.